Loading...
Why Do Immunosuppressed Patients with Inflammatory Bowel Disease Not Seem to Be at a Higher Risk of COVID-19?
The COVID-19 pandemic has created a public health emergency. In this context, there are major concerns for patients with inflammatory bowel disease (IBD), particularly for those treated with immunomodulators, biologics, and Janus Kinase inhibitors. Infection susceptibility is, in fact, one of the re...
Saved in:
| Published in: | Dig Dis Sci |
|---|---|
| Main Author: | |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Springer US
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7569008/ https://ncbi.nlm.nih.gov/pubmed/33073335 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10620-020-06624-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|